{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:38:53Z","timestamp":1776497933082,"version":"3.51.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG074358"],"award-info":[{"award-number":["R01AG074358"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jagp.2025.07.008","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T22:38:42Z","timestamp":1753569522000},"page":"1197-1206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A National Survey of Nursing Home Clinicians to Explain Increased Valproate Prescribing"],"prefix":"10.1016","volume":"33","author":[{"given":"Jonathan D.","family":"Winter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. William","family":"Kerns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danya M.","family":"Qato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Wastila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eposi","family":"Elonge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R.","family":"Reves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J. Christian","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex H.","family":"Krist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca S.","family":"Etz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jagp.2025.07.008_bib0001","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jgs.18119","article-title":"Antiepileptic prescribing to persons living with dementia residing in nursing homes: a tale of two indications","volume":"71","author":"Candon","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.jagp.2025.07.008_bib0002","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jamda.2020.05.039","article-title":"Trends in antipsychotic and mood stabilizer prescribing in long-term care in the U.S.: 2011-2014","volume":"21","author":"Gerlach","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"10.1016\/j.jagp.2025.07.008_bib0003","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/NRL.0000000000000522","article-title":"Trends in antiseizure medication prescribing among nursing home residents with and without a seizure diagnosis","volume":"28","author":"Winter","year":"2023","journal-title":"Neurologist"},{"key":"10.1016\/j.jagp.2025.07.008_bib0004","unstructured":"Depakote (divalproex sodium) boxed label. 1983; https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/018723s069lbl.pdf. Accessed March 19, 2025."},{"key":"10.1016\/j.jagp.2025.07.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1089\/jpm.2024.0560","article-title":"Management of behavioral disturbances in dementia: part 1 non-pharmacologic #498","author":"Bradley","year":"2025","journal-title":"J Palliat Med"},{"issue":"1","key":"10.1016\/j.jagp.2025.07.008_bib0006","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13195-021-00867-8","article-title":"Efficacy and safety of pharmacotherapy for Alzheimer's disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials","volume":"13","author":"Seibert","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jagp.2025.07.008_bib0007","unstructured":"Best Practice Guideline for Accomodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care. 2012; http:\/\/www.health.gov.bc.ca\/library\/publications\/year\/2012\/bpsd-guideline.pdf. Accessed September 6, 2016."},{"issue":"6","key":"10.1016\/j.jagp.2025.07.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.19381","article-title":"Clinician perspectives on increased gabapentinoid prescribing in nursing homes","volume":"73","author":"Winter","year":"2025","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.jagp.2025.07.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2024.105363","article-title":"A nursing home clinician survey to explain gabapentinoid increases","volume":"26","author":"Winter","year":"2025","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"10.1016\/j.jagp.2025.07.008_bib0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/07317115.2024.2379974","article-title":"Understanding long-stay gabapentin use increases: a National Nursing Home Clinician Survey on prescribing intent","volume":"47","author":"Winter","year":"2024","journal-title":"Clin Gerontol"},{"key":"10.1016\/j.jagp.2025.07.008_bib0011","doi-asserted-by":"crossref","DOI":"10.2196\/64446","article-title":"Prescribing trends and associated outcomes of antiepileptic drugs and other psychotropic medications in US nursing homes: proposal for a mixed methods investigation","volume":"13","author":"Winter","year":"2024","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.jagp.2025.07.008_bib0012","doi-asserted-by":"crossref","DOI":"10.1177\/23337214241277052","article-title":"Understanding pandemic increases in long-stay psychotropic prescribing for dementia symptoms: a survey of nursing home clinicians","volume":"10","author":"Kerns","year":"2024","journal-title":"Gerontol Geriatr Med"},{"key":"10.1016\/j.jagp.2025.07.008_bib0013","unstructured":"Rexulti (brexpiprazole) boxed label. 2024; https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/205422s011lblcorrection.pdf. Accessed March 21, 2025."},{"issue":"15","key":"10.1016\/j.jagp.2025.07.008_bib0014","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jagp.2025.07.008_bib0015","first-page":"1-1","article-title":"FDA requests boxed warnings on conventional antipsychotics","volume":"1207","year":"2008","journal-title":"Reactions Weekly"},{"key":"10.1016\/j.jagp.2025.07.008_bib0016","unstructured":"National partnership to improve dementia care in nursing homes: Antipsychotic Medication Use Report (April 2022). 2022; https:\/\/www.cms.gov\/files\/document\/antipsychotic-medication-use-data-report-2021q4-updated-07292022.pdf. Accessed July 30, 2022."},{"issue":"5","key":"10.1016\/j.jagp.2025.07.008_bib0017","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","article-title":"Association of the Centers for Medicare & Medicaid Services' National Partnership to improve dementia care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014","volume":"178","author":"Maust","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jagp.2025.07.008_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2020.104091","article-title":"Efficacy and safety of valproic acid in dementia: a systematic review with meta-analysis","volume":"89","author":"Liu","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"10.1016\/j.jagp.2025.07.008_bib0019","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S1041610207006540","article-title":"Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review","volume":"20","author":"Konovalov","year":"2008","journal-title":"International psychogeriatrics \/IPA"},{"issue":"11","key":"10.1016\/j.jagp.2025.07.008_bib0020","first-page":"942","article-title":"Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial","volume":"13","author":"Tariot","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"10.1016\/j.jagp.2025.07.008_bib0021","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jagp.2025.07.008_bib0022","series-title":"Could Improve the Data It Uses to Monitor Antipsychotic Drugs in Nursing Homes","year":"2021"},{"key":"10.1016\/j.jagp.2025.07.008_bib0023","unstructured":"CMS toughens stance on anticonvulsant use with new MDS reporting requirments. 2024; https:\/\/www.mcknights.com\/news\/cms-toughens-stance-on-anticonvulsant-use-with-new-mds-reporting-requirements\/. Accessed March 21, 2025."},{"key":"10.1016\/j.jagp.2025.07.008_bib0024","unstructured":"Azjen I. Constructing a Theory of Planned Behavior Questionnaire. 2019; https:\/\/submit.napcrg.org\/Presenter\/AddParticipant?SubmissionId=6384. Accessed February 2, 2024."},{"issue":"5","key":"10.1016\/j.jagp.2025.07.008_bib0025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/psyg.13157","article-title":"Lessons learned from CMS's National Partnership to Improve Dementia Care: a thematic synthesis of multiple stakeholder-engaged studies","volume":"24","author":"Winter","year":"2024","journal-title":"Psychogeriatrics"},{"issue":"5","key":"10.1016\/j.jagp.2025.07.008_bib0026","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1080\/07317115.2022.2063777","article-title":"Community, social, and facility factors and long-stay antipsychotic use","volume":"45","author":"Winter","year":"2022","journal-title":"Clin Gerontol"},{"key":"10.1016\/j.jagp.2025.07.008_bib0027","series-title":"Doing Qualitative Research. 3rd Ed","author":"Crabtree","year":"2022"},{"issue":"12","key":"10.1016\/j.jagp.2025.07.008_bib0028","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.jamda.2022.08.017","article-title":"Public quality reporting and nursing home admission decisions","volume":"23","author":"Winter","year":"2022","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.1016\/j.jagp.2025.07.008_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3122\/jabfm.2018.01.170230","article-title":"Primary care physician perspectives about antipsychotics and other medications for symptoms of dementia","volume":"31","author":"Kerns","year":"2018","journal-title":"J Am Board Fam Med"},{"issue":"2","key":"10.1016\/j.jagp.2025.07.008_bib0030","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1093\/geront\/gnx042","article-title":"Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia","volume":"58","author":"Kerns","year":"2018","journal-title":"Gerontologist"},{"issue":"4","key":"10.1016\/j.jagp.2025.07.008_bib0031","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1370\/afm.2979","article-title":"Telemedicine in primary care: lessons learned about implementing health care innovations during the COVID-19 pandemic","volume":"21","author":"Etz","year":"2023","journal-title":"Ann Fam Med"},{"issue":"4","key":"10.1016\/j.jagp.2025.07.008_bib0032","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/13607863.2016.1277974","article-title":"Perceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care","volume":"22","author":"Olivieri-Mui","year":"2018","journal-title":"Aging Ment Health"},{"issue":"4","key":"10.1016\/j.jagp.2025.07.008_bib0033","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40266-018-00636-7","article-title":"Pharmacological management of dementia with lewy bodies","volume":"36","author":"Hershey","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2025.07.008_bib0034","unstructured":"Justice OoPAUSDo. Abbott Labs to Pay $1.5 billion to resolve criminal & civil investigations of off-label promotion of Depakote. 2012; https:\/\/www.justice.gov\/opa\/pr\/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote. Accessed October 24, 2024."},{"issue":"4","key":"10.1016\/j.jagp.2025.07.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/1475-6773.14270","article-title":"Dementia, nurse staffing, and health outcomes in nursing homes","volume":"59","author":"Mukamel","year":"2024","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jagp.2025.07.008_bib0036","doi-asserted-by":"crossref","DOI":"10.1177\/23337214241262914","article-title":"Quality gap in long-stay antipsychotic quality measure performance widens over the pandemic, reversing past gains","volume":"10","author":"Winter","year":"2024","journal-title":"Gerontol Geriatr Med"},{"issue":"38","key":"10.1016\/j.jagp.2025.07.008_bib0037","first-page":"1","article-title":"Long-term care providers and services users in the United States: data from the National Study of Long-Term Care Providers, 2013-2014","volume":"3","author":"Harris-Kojetin","year":"2016","journal-title":"Vital Health Stat"},{"issue":"2","key":"10.1016\/j.jagp.2025.07.008_bib0038","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jamda.2020.10.006","article-title":"The characteristics of physicians who primarily practice in nursing homes","volume":"22","author":"Jung","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"20","key":"10.1016\/j.jagp.2025.07.008_bib0039","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1001\/jama.2017.13378","article-title":"Physicians and advanced practitioners specializing in Nursing Home care, 2012-2015","volume":"318","author":"Ryskina","year":"2017","journal-title":"JAMA"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106474812500421X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106474812500421X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:11:33Z","timestamp":1772881893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S106474812500421X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S106474812500421X"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2025.07.008","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A National Survey of Nursing Home Clinicians to Explain Increased Valproate Prescribing","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2025.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}